
This retrospective cohort study involving 169 vulvar lichen sclerosus (VLS) patients examined the impact of early treatment with mometasone furoate 0.1% ointment on disease progression. Findings revealed a significant association between prompt treatment initiation (within 6 months of onset) and the clearance of subjective symptoms (GSS), objective features (GOS, sclerosis-scarring-atrophy), dyspareunia, and overall symptom relief. Delayed treatment initiation adversely affected symptom clearance. The study underscores the importance of early intervention in achieving complete healing of VLS-related symptoms, particularly tissue sclerosis-scarring-atrophy, suggesting a critical "window of opportunity" in VLS treatment.
Like
Save
Share